 Safety stability effectiveness immunoadsorption membrane plasmapheresis treatment myasthenia gravis Nine patients women men average age years refractory myasthenia gravis MG underwent thymectomy immunoadsorption membrane plasmaphersis IAP Thymic histology hyperplasia patients immunoadsorption column ASAHI Med Co tryptophan Plasouto ASAHI Med Co machine plasma separator first filter ASAHI Med Co immunoadsorption columns plasma perfusion IAP treatment times total times IAP weeks removal rate anti-Ach-R titer IgG IgA IgM levels patients IAP treatment improvement gait disturbances Muscle strength patients whereas disturbances Eye ptosis patients Subjective improvement patients none severe side effects IAP conclusion IAP safe stable effective useful treatment MG